Search

everythinglearnresearchcommunity

for

Search:↓

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Ritlecitinib works well and is safe for treating alopecia areata.

5α-reductase inhibitors may lower the risk of death from bladder cancer.

Rats had lasting erectile problems after stopping a certain medication.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

Fluconazole might be a new treatment for a type of diabetes that affects water balance in the body.

Using minoxidil for hair growth may cause skin lesions in some people, and taking breaks from nitrate patches for angina might worsen symptoms.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Ritlecitinib is effective and safe for treating alopecia areata, promoting significant hair regrowth.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Certain medications can reduce mortality risk in COPD patients, but others can increase risks of cardiovascular issues, postoperative delirium, and other adverse effects.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Finasteride weakens the bone-protective effects of certain blockers in low androgen conditions.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

The NUDT15 R139C variant causes thiopurine-induced leukocytopenia through a different mechanism than previously thought in Japanese patients with inflammatory bowel disease.

Minoxidil effectively lowers blood pressure and initially increases plasma renin activity without raising aldosterone levels.

Rutin may protect against stomach damage caused by sodium valproate.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Agmatine may help reduce seizures linked to hormone changes in female rats.

Ritlecitinib effectively promotes hair regrowth in alopecia areata patients, even with extensive hair loss.

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Certain histamine receptors (H2R, H3R, H4R) have unique roles in treating skin diseases, with H2R helping with chronic urticaria and other conditions, H3R providing pain relief and allergy benefits, and H4R reducing inflammation and itchiness.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

A substance called sodium zinc dihydrolipoylhistidinate can significantly reduce hair loss caused by chemotherapy in rats.

Ritlecitinib effectively regrows hair in adolescents with alopecia areata and is safe.

Compound 3 protects the heart from damage by activating A1-adenosine receptors.